
A four-week public consultation has now officially opened, with a deadline of August 5, 2026.

A four-week public consultation has now officially opened, with a deadline of August 5, 2026.

PPWR imposes on all companies placing packaging on the EU market a full chain of obligations spanning substances, design, and recyclability. Medical device companies are no bystanders — although, given the special nature of their products, the primary packaging in direct contact with the product enjoys certain relaxations with regard to "recyclability" and "recycled content," core responsibilities such as minimization, hazardous substances, labeling, EPR, and the Declaration of Conformity apply in full. There is therefore no such thing as a complete exemption for medical device packaging under the PPWR framework.

The EU Packaging and Packaging Waste Regulation (PPWR, Regulation (EU) 2025/40), will become mandatorily applicable across the entire EU from August 12, 2026, replacing the 94/62/EC Directive that has been in force for nearly 30 years. PPWR is upgraded into a directly applicable regulation and it imposes full-chain requirements on all packaging placed on the EU marke

On 12 August 2026, the EU Packaging and Packaging Waste Regulation (PPWR, Regulation (EU) 2025/40) will become fully mandatory. This is not a "recommendatory" guidance document. It is a regulation with direct legal force, uniformly applicable to all EU Member States. From that date onwards, packaging that fails to meet requirements – including excessive heavy metals, non-compliant PFAS levels, incomplete EPR registration, or missing mandatory labels – may face product delisting, customs detention, heavy fines, or even exclusion from the EU market.

On June 5, 2026, the European Commission published the Guidance Document on the Packaging and Packaging Waste Regulation (PPWR).

On June 3, 2026, ECHA released a briefing on the SEAC consultation for the PFAS restriction proposal, receiving 3,511 comments within a 60-day period.

On 30 April 2026, the Official Journal of the European Union published Decision (EU) 2026/878. The decision clearly states that the European Union, on behalf of its Member States, will submit a proposal to the Secretariat of the Stockholm Convention on Persistent Organic Pollutants (hereinafter referred to as "the Convention") to recommend the listing of bis(2-ethylhexyl) tetrabromophthalate (abbreviated as TBPH) in Annex A (Elimination) of the Convention.

RAPEX, as the EU's rapid alert system for non-food dangerous products, has issued multiple notification cases for fluorinated compounds such as PFAS, PFOA and PFCAs, covering clothing, textiles, outdoor equipment and other product categories. These notifications reflect the EU's strict regulatory requirements and high-intensity law enforcement for PFAS residues in consumer products, and also bring clear compliance challenges to global manufacturers, exporters and cross-border e-commerce platforms.

On March 30, 2026, the European Commission released the guidance document and accompanying Frequently Asked Questions (FAQ) for the PPWR.

On January 29, 2026, the European Commission published Directive (EU) 2026/192, amending the Toy Safety Directive 2009/48/EC to permit the use of cobalt in three specific applications within toys.